Prostate Cancer
Relevance: High
Most relevant for: People diagnosed with cancer
Topic: Acupressure for cancer symptom relief
Acupressure is a safe treatment that can be used to relieve some symptoms of cancer and side effects of treatment. Light pressure applied to key points on the body may help with fatigue, sleep, nausea and possibly other symptoms as well. (Posted 8/1/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with advanced HER2-positive cancer
Topic: The drug Enhertu is FDA-approved for any advanced or metastatic HER2-positive tumors
The FDA granted accelerated approval of Enhertu for people with any HER2-positive tumor that is metastatic or cannot be surgically removed. Eligible patients must have had previous treatment such as chemotherapy or hormone therapy. (Posted 7/19/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: Cancer patients
Topic: Experts call for early palliative care for cancer patients
People with cancer need support and care not only at the end of life but from the time of diagnosis. At the 2024 American Society of Clinical Oncology (ASCO) annual meeting, the organization’s president urged cancer healthcare professionals to make palliative care central to cancer treatment. (Posted 7/17/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Most relevant for: People diagnosed with cancer who have not yet had genetic testing
Study: Genetic testing among people with cancer can find mutations that may affect treatment and prevention
Despite national guidelines recommending genetic testing, less than 10 percent of eligible patients had genetic testing within two years after their cancer diagnosis. Among those who had testing, 10-30 percent had an inherited mutation that could affect their medical care. (Posted 3/15/2024)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People diagnosed with advanced prostate cancer
Study: Genes linked to aggressive prostate cancer
Previous research has linked some inherited mutations to prostate cancer risk. This study found a link to additional genes that should be added to prostate cancer gene panel tests. The study also looked at which genes were most closely linked to aggressive prostate cancer that is more likely to spread. (Posted 2/1/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with metastatic castration resistant prostate cancer with a mutation in BRCA1 or BRCA2
Update: New drug combination approved for treatment of BRCA-mutated metastatic prostate cancer
The FDA approved Akeega (niraparib and abiraterone) plus prednisone for the treatment of BRCA-mutated, metastatic castration-resistant prostate cancer (mCRPC). Akeega can be used as an early or later treatment. (Posted 11/9/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with metastatic castration resistant prostate cancer who have an inherited or tumor mutation in certain genes.
Update: New first-line treatment option for metastatic prostate cancer
The FDA has approved Talzenna (talazoparib) with Xtandi (enzalutamide) as first-line treatments for some patients with metastatic castration-resistant prostate cancer. (Posted 10/2/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Most relevant for: People interested in genetic testing.
Article: Genetic testing and the future of medicine
An article published in Katie Couric Media discusses genetic testing and how it can impact health. The author talked with Dr. Robert Steiner, a doctor who specializes in genetics. He talked about genetic testing and how the results can affect health and change lives. (Posted 9/28/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: Gay and bisexual men diagnosed with prostate cancer
Topic: Sexual health concerns of gay and bisexual men with prostate cancer
Prostate cancer therapy can affect gay and bisexual men differently than heterosexual men. Many urologists do not routinely address these unique concerns. Selecting providers who understand the concerns that are unique to gay and bisexual patients and asking questions about sexual health concerns may improve these patients' healthcare experiences. (Posted 9/21/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with metastatic castration resistant prostate cancer with a mutation in BRCA1 or BRCA2
Update: New drug combination for early treatment of some metastatic prostate cancer
The FDA approved Lynparza (olaparib) for use earlier in treatment of metastatic castration-resistant prostate cancer (mCRPC) when added to abiraterone and prednisone for people with a BRCA mutation found through genetic or tumor testing. Lynparza combined with hormone therapy may now be used as a first-line or later treatment. (Posted 9/11/23)
Este artículo está disponible en español.
READ MORE ›